Anti‐ORAI1 antibody DS‐2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T‐cell and mast cell activation-Reference-Cited by-同舟云学术

Anti‐ORAI1 antibody DS‐2741a, a specific CRAC channel blocker, shows ideal therapeutic profiles for allergic disease via suppression of aberrant T‐cell and mast cell activation

Published:2020-07-08 Issue:8 Volume:2 Page:478-488
ISSN:2573-9832
Container-title:FASEB BioAdvances
language:en
Short-container-title:FASEB BioAdvances

Author:

Aki Anri¹,Tanaka Kento²,Nagaoka Nobumi³,Kimura Takako⁴,Baba Daichi⁵,Onodera Yoshikuni⁶,Wada Teiji²,Maeda Hiroaki⁷,Nakanishi Toshiyuki⁷,Agatsuma Toshinori²,Komai Tomoaki⁸

Affiliation:

1. R&D Division Specialty Medicine Research Laboratories I, Research FunctionDaiichi Sankyo Co., Ltd. Tokyo Japan

2. Oncology Function R&D Division Oncology Research Laboratories IDaiichi Sankyo Co., Ltd. Tokyo Japan

3. Biologics Division Modality Research Laboratories Daiichi Sankyo Co., Ltd. Tokyo Japan

4. Structure‐Based Drug Design Group Organic Synthesis Department Daiichi Sankyo RD Novare Co., Ltd. Tokyo Japan

5. Quality & Safety Management Division Post‐Marketing Regulatory Affairs Department Daiichi Sankyo Co., Ltd. Tokyo Japan

6. Vaccine Research Laboratories Biologics Division Daiichi Sankyo Co., Ltd. Tokyo Japan

7. R&D Division R&D Planning & Management Department Daiichi Sankyo Co., Ltd. Tokyo Japan

8. R&D Division R&D General Affairs & Human Resources Department Daiichi Sankyo Co., Ltd. Tokyo Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fba.2020-00008

Reference45 articles.

1. Atopic Dermatitis

2. Guidelines for treatment of atopic eczema (atopic dermatitis) Part I

3. An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease

4. Systemic Treatment of Adult Atopic Dermatitis: A Review

5. Guidelines for treatment of atopic eczema (atopic dermatitis) Part II

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orai1 Ca2+ channel modulators as therapeutic tools for treating cancer: Emerging evidence!;Biochemical Pharmacology;2024-01

2. House dust mite allergens, store‐operated Ca²⁺ channels and asthma;The Journal of Physiology;2023-12-06

3. Stabilization of activated mast cells by ORAI1 inhibitor suppresses peanut-induced anaphylaxis and acute diarrhea;Pharmacological Research;2023-10

4. Super resolution microscopy analysis reveals increased Orai1 activity in asthma and cystic fibrosis lungs;Journal of Cystic Fibrosis;2023-01

5. PLC-IP3-ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal mast cells;Immunology Letters;2022-08